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ABSTRACT
Magnetic Resonance Spectroscopy (MRS) is a useful tool for obtaining in-
formation about metabolite concentrations. Information that can be ex-
trapolated from these concentrations may be absolute or relative in nature,
depending on the availability of an internal reference. For example, MR
Thermometry using Single Voxel Spectroscopy (SVS) utilizes the water peak
as an internal reference to observed metabolites offering a means of inter-
preting absolute metabolite values. On the other hand, metabolite mapping
is best performed by utilizing water suppression since the water peak is of a
magnitude 104 times larger than metabolite peaks. In this case metabolite
information is characterized relative to other metabolites and a metabolite
of interest is given as a percentage.
Sensitivity in MRS is of the utmost concern since metabolites appear at
such small concentration in the brain. Thus, metabolite peak position using
a Guassian and Hamming filters and the adaptation of chemical shift imaging
from 2D to 3D is useful in obtaining more precise information.
Herein, it is shown that both absolute and relative quantification can be
improved through, respectively, frequency filters and increased dimensional
acquisition.
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CHAPTER 1
INTRODUCTION
1.1 Overview
In 1946, the discovery of Nuclear Magnetic Resonance (NMR) was made
by both Felix Bloch [10] and Edward Purcell [9]. In vitro determination
of molecular structure and metabolite interaction are important biophysical
information that can be analyzed with NMR [33, 35, 34]. Magnetic Reso-
nance Imaging (MRI) is based on the principle of NMR and provides a high
contrast non-invasive in vivo tool for visualization of normal and abnormal
tissues through diverse body regions. An MRI scanner can be used to create
metabolite images using Magnetic Resonance Spectroscopy (MRS). The pulse
sequences utilized to generate data in MRI differs from those used in MRS.
Magnetic Resonance Spectroscopy Imaging (MRSI) combines spectroscopic
and imaging techniques for visualization of the distribution of metabolites
within a tissue of interest.
The challenges in MRS data acquisition include motion, suppression and
separation of water and lipids from metabolite peaks, and low concentrations
of metabolites of interest. Motion, such as pulsatile flow prevents quality
shimming, resulting in increased linewidths of metabolite peaks. Insufficient
suppression/separation of water and lipids from metabolite peaks causes lack
of differentiability between metabolite peaks and difficult visibility of those
metabolites with low concentrations [37]. The overall low concentration of
metabolites with respect to water/lipids [37] in the brain makes resolving
metabolites difficult. As compared with other areas of the body, the brain
lacks accessibility for biopsy [36], thus, critical diagnostic information is ac-
quired via imaging techniques. Critical advantages of MRS brain studies
compared to other areas of the body are:
1. relative ease of shimming due to the spherical shape and minimal mo-
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tion and
2. neurometabolite peaks are separated from lipid peaks allowing better
resolution of the peaks of interest.
To achieve optimal MRS data the following must be performed:
1. shimming to eliminate peak broadening due to magnetic susceptibility,
2. pulse angle calibration,
3. correct echo and repetition times (TE and TR) for the metabolites of
interest which vary in longitudinal and transverse relaxation rates (T1
and T2 or T2*).
The experimental parameters herein reflect the optimal values for collection
and vary between experimental types and applications.
1.2 MRSI
MRSI is an imaging technique that gathers spectral signals from metabolites
in a region of interest (ROI). Chemical shift is the subtle change in frequency
of a metabolite signal which allows for differentiation between materials and
evaluation of the physiology of various regions in vivo.
Chemical shift results from a displacement of the resonance frequency
caused by electron cloud shielding from the much larger Bo field induced
by an MRI. Placement of a sample in a uniform magnet and excitation with
radio frequency pulses results in a decaying signal called the Free Induction
Decay (FID) [7]. Taking the Fourier Transform of the FID offers visual-
ization of the MR spectrum which contains peaks at different frequencies
corresponding to their respective chemical shifts [7].
The field experienced by a metabolite is determined by the strength of the
main magnetic field, Bo, through the following relationship with the shielding
constant, σ:
Beff = Bo −Boσ = Bo(1− σ) (1.1)
Application of the Larmor relationship (ω= γB) gives equation 1.1 in terms
of frequency:
ωeff = ωo − ωoσ = ωo(1− σ) (1.2)
2
Equations 1.1 and 1.2 demonstrate that displacement of the resonance fre-
quency is proportional to Bo. The expression of resonance frequency dis-
placement with respect to a reference frequency provides a means of data
comparison across scans with different Bo strengths.
By convention, the frequency axis in MRSI decreases from left to right. The
amplitude of peaks increases depending on the number of protons present.
Figure 1.1: Sample Proton Spectrum
As shown in figure 1.1, the example spectrum has a higher peaks corre-
sponding with a larger number protons. Moreover, these groups maintain
different chemical shifts and thus the least shielded group (CH) is shifted
from the resonant frequency more than the most shielded group (CH3).
1.3 J-Coupling
Beyond chemical shift, the properties of a metabolite are shown in a spec-
tra through a splitting behavior referred to as J-coupling. This principle
describes the characteristics of nuclei in close proximity to one another influ-
encing each other’s magnetic fields. The protons in a metabolite, in addition
to being shielded by valence electrons, are each influenced by the small mag-
netic fields generated by other surrounding metabolite protons. The mag-
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Figure 1.2: Spin Transition States
netic moment of a surrounding metabolite is aligned with or against (spin:
± 1
2
) Bo. The Beff felt by the initial metabolite is slightly weaker if the sur-
rounding metabolite is aligned against (spin: -1
2
) Bo or slightly stronger if
it is aligned with (spin: +1
2
) Bo. While the metabolite protons may experi-
ence shielding completely with or against Bo, there exists a state where they
may experience different shielding effects: one may have aligned Bo influence
while another may have opposed Bo influence. The possible configurations
are visualized in figure 1.2, illustrating the four possible spin transition states
for a hypothetical nucleus with two protons.
1.4 Neurometabolites
MRSI is an important technique in the quantification of biochemical com-
pound concentration. Abnormal levels of such these metabolites can be in-
dicative of stress, functional disorders, or disease. Some of the key neu-
rometabolites and their roles are discussed in more detail below.
Glutamate and Gamma-Aminobutyric Acid (GABA) are the main ex-
citatory/inhibitory neurotransmitters in the brain [31]. Variability in the
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metabolism of these metabolites alters brain excitability. Glutamate is the
metabolic precursor for GABA, the metabolites of which have anticonvulsant
properties and great impact on brain excitation [31].
N-Acetylaspartic Acid (NAA) is a derivative of aspartic acid and found in
healthy neurons [24]. It gives off the largest MRS signal in the brain. De-
creased levels indicate pathological conditions ranging from stroke to Alzheimer’s
disease [24], which makes NAA a valuable and reliable diagnostic metabolite.
Choline is an essential nutrient needed for myelination of nerves and a pre-
cursor for acetylcholine–an important neurotransmitter involved in memory
and muscle action [17]. Choline is also used in the synthesis of phospholipids,
phosphatidylcholine, and sphingomyelin which are structural components of
cell membranes and precursors for cell-signaling molecules [51]. Studies in
laboratory rats have shown that choline deficiency during the perinatal stage
causes persistent memory and cognitive deficits [39].
Creatine deficiencies are rare [26] so this metabolite can be utilized as
an internal reference with which to create ratios with other metabolites for
standard comparisons of other areas in the same subject or in other subjects.
Creatine, normally obtained from the diet, is distributed heterogeneously
throughout the brain and contributes to normal mental function [26].
Essential Fatty Acids are modulated by dietary intake and influence neuro-
transmission, prostaglandin formation, and maintain processes vital to nor-
mal brain function [13].
1.5 Pre-Processing
MRS preprocessing steps and quantitation are performed either in the time
or frequency domain. The time domain signal consists of a mixture of differ-
ent damped sinusoid signals which are unique and characterized by certain
physical parameters (resonance frequency, damping factor, individual phase
and amplitude at t = 0). The amplitude of the time-domain signal is di-
rectly proportional to the number of molecules, the decay constant of the
signal characterizes the mobility of the molecules and the frequency of the
spectral components characterizes the identity of the molecules [45]. Accu-
rate and efficient quantitation of MRS signals is accomplished with the help
of appropriate model functions and is, therefore, an important step to esti-
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mate the intrinsic signal parameters and convert the estimated parameters
into metabolite concentrations. Theoretically, the time domain signal can
be modeled by a sum of exponentially damped complex sinusoids, where k
is assumed to be a known number of expected sinusoids of N time domain
data samples and the amplitude Ak is proportional to the number of nuclei
contributing to the spectral component.
S(tn)n=0,1,...,N−1 = ao +
k∑
k=1
Ake
jδφke(−dk+j2pifk)tn (1.3)
Analysis of time domain data is comprised of preprocessing of the MRS
data, followed by quantitation of the FIDs using prior knowledge (relations
between the spectral components involving amplitudes, damping ratios, fre-
quencies and phases)
1.5.1 Time Domain
As indicated earlier, the acquired MRS data is not ideal due to embedded im-
perfections originating from experimental conditions. Hence, preprocessing
of MRS data is required to eliminate certain imperfections. Steps involved
in the preprocessing of MRS data in the time domain are as follows:
Eddy current compensation Eddy currents occur due to magnetic field
gradients generated during MRS data acquisition. Eddy currents induce
time-varying magnetic fields, which in turn cause either frequency-dependent
phase shifts, or dephasing (signal loss) of the observed time domain signal
[43]. Hence, distortion in signal shape is observed leading to inaccurate
spectral quantitation. The recovery from eddy current corrected signal is
accomplished by dividing the water suppressed time domain MRS signal
point-wise by the phase part of the unsuppressed water signal [43].
Offset correction The DC (direct current) offset voltage occurs due to
the leakage of transmitter reference frequency into the receiver resulting in
non-zero mean of free induction decays. Hence, at zero frequency, a spike
is generated in the resulting spectrum. The unwanted spike is eliminated
during preprocessing period.
Noise filtering Noise is a time domain random function with certain stan-
dard deviation, which is embedded with the acquired signal. It is assumed
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that in MRS signal, the noise is Gaussian type with zero mean and constant
standard deviation. The SNR of MRS signal is correlated with the signal
amplitude divided by the standard deviation of the noise. Noise in MRS
signal is caused either due to the thermal motion of the charged particles
in the sample and/or the thermal motion of the electrons in the coil and
receptor paths [11]. Hence, noise reduction is an important objective for
SNR improvement. Generally, matched filter is used for noise reduction and
the function of such matched filter is similar to pattern of signal decay. For
clarity, the matched filter is an exponential decay function with the decay
characteristic equal to T2 * of the FID. The selection of the matched filter
is not straightforward for multi-compartment FID where compounds have
different T2* values [11] [38] . Selection of other filter functions has impact
on the line-shape.
Zero filling Digitized data points in the time domain can be extended with
a set of zeros. This implies that part of the signal, which may not have
been digitized within the acquisition window, have been fully relaxed and
have zero value. The effect of zero filling is to enhance resolution leading to
improved spectral visualization only. Data storage space increases depending
on the extent of zero filling applied.
Residual water suppression Various algorithmic approaches have been ap-
plied for the estimation of water component. One strategy is to use low-pass
convolution, which suppresses all high frequency components of the spectrum
leaving only an estimate of the residual water [25]. Another strategy is to
model the water component of the time domain signal as a sum of multiple
exponentially damped sinusoids using the HSVD (Hankel Singular Value De-
composition) algorithm [46]. The water signal modeled using either of these
techniques is then subtracted from the observed MRS spectrum, leaving only
the metabolite signals of interest.
Quantitation The concentration of the metabolites in a certain localized
soft- tissue region is determined by computing the parameters of a certain
time domain model function as shown in Eq. 1.3. In time domain, there
are two approaches for the quantitation of metabolites: iterative methods
and non-iterative methods. In the iterative methods, typical NLLS (non-
linear least squares) methods are used to minimize the difference between
the data and the model function using local or global optimization. An-
other important feature of the iterative methods is the inclusion of prior
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knowledge (e.g. frequencies, damping factors and phases of some exponen-
tials). One of the early methods of imposing prior knowledge onto the ob-
served signal is the VARPRO (variable projection) method [47]. VARPRO
method assumes a Lorentzian line-shape for the individual components of
the resonances and fits corresponding decaying exponentials in the time do-
main. This iterative methodology in time domain data fitting was further im-
proved by AMARES (Advanced Method for Accurate, Robust and Efficient
Spectral)[1]. AMARES fitting enables the incorporation of more prior knowl-
edge on the spectral parameters to increase efficiency, convergence rates,
overall accuracy, and can also be extended to fit echo signals. AMARES
is preprogrammed to switch between Lorentzian, Gaussian or Voigt model
line-shape.
Non-iterative methods are either based on the linear prediction principle or
based on the state-space theory like HSVD [12]. Non-iterative methods are
less flexible than the iterative methods for the inclusion of prior knowledge,
and hence these methods are less suitable for more complicated analysis as
required in time MRS signals. In non-iterative methods, model function is
confined to only exponential decay and model parameters are chosen in one
single step.
Model fitting yields the contribution of each input signal. Usually, Cramer-
Rao lower bounds (CRLB) provide an estimate for the fitting error or the
statistical uncertainty of the metabolic concentration estimate.
1.5.2 Frequency Domain
Certain preprocessing steps (e.g. eddy current compensation, offset cor-
rection, apodization) are common to both frequency and time domain and
are pictured in figure 1.3. In the frequency-domain, three additional steps
namely, phase correction, residual water suppression and baseline correction
are applied. Brief description of these preprocessing steps is given below.
Phase correction Distortion of resonance peak shape can be addressed via
phase correction. Phase correction consists of two steps: zero order phase
correction and first order phase correction and may be implemented manually
or automatically [42]. In zero- order phase correction, the same degree of
phase correction is implemented for all resonance peaks. Then, in first-order
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phase correction, the amount of phase correction effect is dependent on the
individual peak [42] under consideration.
Baseline correction This is an important step as inaccurate baseline cor-
rection is one of the major sources of variability in quantitation of metabo-
lites. Due to the presence of residual water and/or strong signals arising
from lipids, phase corrected spectra are distorted [42]. Baseline can be cor-
rected manually but in most programs (LCModel, jMRUI, etc.) it is done
automatically.
Residual water suppression Generally, the resonance frequency of water
is different compared to other metabolites, so filters can be used to remove
those specific frequency ranges. One approach is to shift water spectrum to
zero frequency using a low pass filter and subsequently subtract it from the
original signal. Another approach is to remove the water signal by applying
high pass filtering to the FID. In the above two approaches, improper filtering
may influence the actual signals of the metabolites which in turn decrease
the accuracy of quantitation.
Quantitation In the frequency domain, metabolite quantitation is accom-
plished by either integration of the area under the peak or nonlinear least
square fitting using model functions. Peak area integration methods works
well when peaks in the spectra are well resolved. However, in vivo studies
often have complex spectra with many overlapping peaks so quantitation
of a spectrum is best accomplished by model-based optimization algorithms
based on the regularized nonlinear least squares method [41]. An ideal MRS
spectrum would consist of a pure Lorentzian line; however, in reality, MRS
signals consist of a mixture of Lorentzian (with A weighted factors) and
Gaussian (with factor G and noise W) curves [21], which are characterized
by equation 1.4. A polynomial of order N with can be used to model the
baseline and ν N is obtained through non-linear least squares.
S(f) =
N∑
N=1
A1LN(νNf ) +
N∑
N=1
A2GN(νNf ) +
N∑
N=1
BNf
N +W (f) (1.4)
Several fitting algorithms operate in the frequency domain, allowing for
inclusion of prior knowledge (i.e. amplitude, damping ratios, frequency, and
phase shifts) and relationships between spectral components [21] [5]. Prior
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knowledge plays an important role in the resolution of overlapping peaks,
fitting noisy spectra with expected line-widths, and improving accuracy of
estimates [21].
1.6 Problem Description
Herein, we explore MRS techniques and apply them to thermometry and
metabolite mapping. By adapting product sequences we are able to ob-
tain increasingly high resolution spectroscopy data which can be interpreted
through analytical techniques and available software. Our goals for this work
are:
• Use of Single Voxel Spectroscopy in Thermometry
• Adaptation of 2D Chemical Shift Imaging to 3D Chemical Shift Imag-
ing
• Segmentation and Metabolite Mapping
1.7 Thesis Organization
Chapter 2 examines the use of single voxel spectroscopy in thermo-manipulated
systems. We present the adaptation of the 2D Chemical Shift Imaging se-
quence to a 3D CSI in chapter 3, briefly describe the encoding implementa-
tion of our technique, and discuss the associated results. Segmentation and
Metabolite Mapping of CSIs are presented in chapter 4. We conclude with
a discussion of the future directions of the information presented in chapter
5. The appendices include documentation on procedures for the techniques
discussed.
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Figure 1.3: Several preprocessing steps are common to both the frequency
and time domain. (a) depicts spectral data in the form of a FID with the
xaxis in ppm for consistency, although this data is conventionally presented
in the time domain. (b) Eddy currents result in dephasing in a spectra as
seen by the circled portion of the upper spectra The corrected spectra is
directly below. (c) A spectra with a high degree of offset is shown in red.
The blue line is the amount the data needs to be corrected and the black
line is the corrected spectra. (d) Zero-filling is the process by which a FID
is elongated. The result looks like the spectra comprised of red dots where
the original spectra is made up of blue dots. There are many more red dots
that follow a much smoother line than there are blue dots. (e) The goal of
apodization is to utilize some set of filtering parameters on data (blue) with
the goal of smoothing noise and increase signal amplitude (green). (f)
Phase and Baseline correction fix any magnetically induced distortions on
the signal, but carefully collected basis sets are required to do this, so it is
best to use LCModel to do this or jMRUI if basis sets are available. (g)
Finally, a spectra with metabolite peaks (circled in red) is created. Water is
at 4.5-4.7 ppm depending on if the sample is biological or at room temp.
NAA is shifted 2.0 ppm to the right of the water peak. Cr is 3.0 ppm away
from the water peak. Cho is 3.2 ppm away from the water peak. The peak
from fat in biological samples ranges from 3.5-4.1 ppm away from the water
peak and is a large, broad peak.
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CHAPTER 2
SVS: THERMOMETRY
The most commonly used methods for non-invasively measuring temperature
in the brain are magnetic resonance based [44]. In particular, most tech-
niques exploit the temperature dependence of the water proton resonance
frequency (PRF). The PRF of water molecules depends on the locally expe-
rienced magnetic field determined by electron shielding of hydrogen bonds.
Shielding increases with temperature, which, in turn, decreases the magnetic
field and thus the PRF [44] [19]. Temperature dependence was first observed
by Hindman who identified the frequency shift with temperature change to
be approximately -0.01 ppm/C over a wide range of temperatures [15].
PRF shift thermometry was first developed using proton magnetic res-
onance spectroscopy (MRS). Here, the PRF shift is calculated relative to
another metabolite peak readily visible in the spectrum that is insensitive
to temperature. Thermometry of the brain most commonly uses N-acetyl-
aspartate (NAA) as the reference peak [3, 4]. In contrast to other tempera-
ture insensitive peaks including choline, creatine, and lactate, NAA exhibits
high amplitude, no overlap with nearby peaks, and is readily visible in both
the ischemic and non-ischemic brain [3, 4]. Alternatively, temperature mea-
surements can be made from all prominent metabolite peaks independently
and combined while weighted by the relative amplitude of the respective
peaks, as reported by Cady et al [8]. This technique improved the repeata-
bility of temperature measurements to between 0.3 and 0.5C, while also re-
ducing sensitivity to pathology where an individual peak may have a reduced
amplitude. Additionally, the use of an internal reference allows for absolute
temperature measurements from MRS thermometry, but requires a careful
calibration of the PRF shift relative to the chosen metabolite peak [23, 20].
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2.1 Motivation
In vivo body temperature is generally measured through surface methods
near the tissue of interest, as to remain noninvasive, or using a thermocouple
microprobe with an invasive technique [22, 50]. There is a specific need for
highly accurate, noninvasive thermometry techniques when measuring brain
temperature, which can be useful in induced focal cerebral hypothermia (or
brain cooling). This technique has been utilized to achieve neuroprotection
in traumatic neurological incidents including cardiac arrest, traumatic brain
injury, and stroke [16].
MR based thermometry is a noninvasive technique with inherently visual-
izable spatial distribution. There are a few feasible options to take such a
measurement. One option utilizes spin-lattice decay time (T1), but is diffi-
cult due to thermo-regulatory perfusion changes during cooling/heating [49]
which may cause hysteresis effects between signal intensity and temperature.
Monitoring perfusion changes correlative to temperature is another option,
however, the high sensitivity to tissue motion cannot be reconciled with dif-
fusion based thermometry [28], although line scanning can reduce motion
sensitivity [28, 29]. PRF (introduced by Ishihara et al. for measurement of
temperature related frequency shifts in gradient echo (GRE) sequences [14])
utilizes a standard GRE and has a short acquisition time; however, it is sub-
ject to the drift of the external magnetic field and thermal influx. Herein,
we utilize SVS techniques to monitor PRF shifts and correct for external
magnetic field drift using water frequency correction.
2.2 Method
Single Voxel Spectroscopy (SVS) An SVS consists of a 90 degree pulse fol-
lowed by either two 180 degree pulses or another 90 degree pulse and a final
180 degree pulse in order to obtain a free induction decay (FID). The ini-
tial SVS is preceded by an automated shim to ensure the full width half
max is below 20 and each subsequent SVS is preceded by a water frequency
adjustment to prevent negetive effects by the external magnetic field drift
on the resolution of the peaks. It was determined that the water frequency
re-adjustment was the best approach to reduce field inhomogeneity later in
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testing, so the phantom and biological sample did not utilize this technique;
however, were shown to have a minimal degree of inhomogeneity by sampling
over time with no temperature change and observing an insignificant degree
of frequency shift during the period of time with no temperature change.
The human subject is more susceptible to frequency shift due to internal
regulatory mechanisms and thus requires more correction than the phantom
or deceased biological sample.
Phantom Experimentation began with a phantom of water and NAA vials
which were cooled in a controlled fashion by wrapping the phantom with
tubing flowing with water controlled by a temperature bath and pump. Tem-
perature of the phantom was monitored using a luxatron temperature probe
on the surface of the phantom.
Biological Sample Similarly to the phantom, a sacrificed rat was cooled and
warmed using water bath regulated water flowing through tubing wrapped
around the sample. The biological sample temperature was measured inter-
nally via insertion of the luxatron probe into the oral cavity.
Human Subject Protocol on a human subject was approved by the insti-
tutional review board (IRB). A helmet with water flow channels was placed
on the human subject. Cold water was pumped through during cooling and
room temperature water during warming. The frequency was re-centered
before each SVS to minimize field inhomogeneity, as discussed previously.
The luxatron probe monitored the temperature from the skin surface of the
forehead of the subject.
2.3 Thermometric Temperature Estimation
Phantom In a phantom made of water and NAA, a cooling trend was ob-
served. However, the observed
ppm
°C
was off by a factor of three. While the
value of the temperature coefficient is off, it should be noted that the data
indicates the proper trend with a decreased ppm indicating a higher tem-
perature (figure 2.1). Since the temperature of the phantom was measured
from an external surface, and questionable accuracy, it is plausible that the
measured temperature values are incorrect.
δliteraturerange
°C
= −0.009− 0.0135 (2.1)
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δobserved
°C
=
(δstartP t − δendPt)
(tempstartPr − temp− endPt) = −0.0030 (2.2)
Using jMRUI software, the temperature can be calculated from the spectra.
When utilizing this information and an associated temperature calibration
equation [2], seen in equation 2.3, that determines the difference between
the water and metabolite peak, a more accurate temperature coefficient for
water can be obtained. As seen in equation 2.4, a value within the expected
coefficient range was found. The calculated temperature versus delta of the
phantom are plotted in figure 2.2.
Tbrain = a− [b ∗ (δH2O−ref + c)] (2.3)
δcalculated
°C
= −0.0121 (2.4)
Biological Sample In the biological sample, a cooling trend is observed. The
parts per million (ppm)-shift increases when temperature decreases. This
trend is consistent with the literature, although the temperature coefficient
is slightly larger than the accepted literature range.
δmeasured
°C
= −0.0163 (2.5)
Some of the variability observed in figure 2.3 is possibly due to small
thermocapacity of this biological sample and the lack of internal thermoreg-
ulation. Moreover, the limitations of the shim volume over a region as small
as a rat brain further increase the chance of anomalies in this type of sample.
However, the fact that we were able to find near-expected ppm-shifts in the
appropriate direction despite the known field inhomogeneity of the sample is
a positive indicator.
During rewarming, it was observed that the ppm-shift did not follow the
cooling ppm-shift as closely as would be expected. Perhaps this is due to an
inaccurate monitoring of the core temperature of the sample.
When the calibrated temperature equation is utilized to calculate temper-
ature, a temperature coefficient within the expected range is acquired.
δcalculated
°C
= −0.0121 (2.6)
The calculated temperature change for the biological sample is plotted in
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figure 2.4. Since the calculated temperature is a linear function of delta,
the points in figure 2.4 become linear whereas there is some deviation from
linearity that can be observed in 2.3. This corrects for the lack of reliability in
the temperature measurement of the luxatron probe; however, it also shifts
data outliers to a more suitable temperature region. Thus, these outliers
should be removed from the data before the calculated temperature matrix
is created.
Human Subject Cooling in a human subject has not been positively identi-
fied through the observed values. It is posited that cooling the brain triggers a
biological response that increases blood flow to the region of cooling, thereby
preventing a core temperature drop. The measured difference between the
water and NAA peaks was within the range of 2.66 ppm and 2.67 ppm (figure
2.5), with the exception of outliers.
Figure 2.6, illustrates the calculated temperatures based on the observed
delta values. This analysis reveals an increase in temperature results in a
decrease in ppm, as expected. It should be noted in this data set, outliers were
not removed in order to show how these points will be shifted inappropriately
to an unreasonable temperature.
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Figure 2.1: Phantom: δ(Water-NAA) vs Measured
Temperature Change. Measured temperatures were
taken with the luxatron probe.
Figure 2.2: Phantom: δ(Water-NAA) vs Calculated
Temperature Change. Calculated values are determined
using jMRUI and equation 2.3.
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Figure 2.3: Biological Sample: δ(Water-Lipids) vs
Measured Temperature Change is depicted in blue and
the trend line for warming/cooling is shown in red.
Figure 2.4: Biological Sample: δ(Water-Lipids) vs
Calculated Temperature Change. Calculated
temperatures are determined using jMRUi and the
equation 2.3.
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Figure 2.5: Human: δ(Water-NAA) vs measurement
number is depicted in blue points for cooling and red
points for warming and the trend line for
warming/cooling is shown as a solid red line.
Figure 2.6: Human: δ(Water-NAA) vs Calculated
Temperature Change. Calculated temperatures are
determined using jMRUi and the equation 2.3.
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CHAPTER 3
2D AND 3D CHEMICAL SHIFT IMAGING
Chemical shift is a phenomena seen when isotopes posses a nuclear magnetic
dipole moment and resonate in a magnetic field at a resonance frequency
shown in a spectrum. The resonance frequencies are dependent upon the
chemical environments of a particular nuclei. Mapping the spatial distribu-
tion of nuclei associated with a particular chemical shift is called chemical
shift imaging. Acquiring high resolution spectra for large numbers of volume
elements in two or three dimensions may be inhibited by time constraints.
However, other collection methods (i.e selective excitation, selective satu-
ration, variation of conventional MR imaging pulse sequences) can provide
quality chemical shift information and spectra. Such techniques require less
time, but they also obtain reduced spectral information.
3.1 Motivation
SVS is a robust method for obtaining a signal from a specific tissue region;
however, 2D and 3D chemical shift imaging (CSI) are designed to cover larger
regions of the brain and provide spatially resolved spectra throughout the se-
lected plane or volume. Both 2D and 3D CSI can be used to investigate the
entire brain, although generally it is used to analyze specific brain regions at
higher resolution than SVS can provide. CSI differs from SVS in that the ex-
cited voxel created by the sequence RF pulses (similar to a PRESS/STEAM
sequence) is subdivided into more resolved voxels by the phase encoding
process (created by griding the original ROI).
A CSI acquires a spectrum at each voxel of a 2- or 3- dimensional grid and
subsequently reconstructs an entire MR spectrum at each voxel, rather than
a single intensity value for each voxel as in MRI. MRS display the signal from
nuclei with different chemical shifts and, as in SVS, the signal can be resolve
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by measuring over a sufficient time period and sampling interval. Measuring
the signals while the echo occurs precludes the use of frequency encoding as
a means of creating spatial resolution. Thus, phase encoding is used for all
spatial directions to obtain spatially resolved spectra. For example, if a 2D
CSI is performed with 8 phase encoding steps in each direction, a spectrum
will be reconstructed in an 8x8 grid, equating to 64 unique spectra from 64
unique spatial regions. If a 3D CSI is performed with 8 phase encoding steps
in each direction, a grid of 8x8x8 voxels with reconstructed spectrum will
give a total of 512 unique spectra in unique spatial regions.
The primary advantage of CSI over SVS is spatial resolution. The SNR
of a CSI acquisition for a given period of time is equivalent to the SNR of
a SVS acquisition of the same duration, but the CSI acquisition provides
information about metabolite concentrations across a range of spatial loca-
tions. 3D CSI uses a greater slice thickness than 2D because in an MxNxP
matrix, the P dimension voxels are phase encoded to create multiple smaller
voxels. This requires a longer acquisition time for a spatially resolved spec-
tra (TR*M*N*P seconds), since only one phase encode step can be set up in
each TR interval. However, SNR is increased due to the larger volume since
SNR is proportional to voxel volume and the square root of the amount of
data collected.
Under certain circumstances 3D CSI can be used to acquire a larger FOV
without a penalty in acquisition time or SNR. For example, if you acquired
4 averages of a 2D CSI data set. In the same amount of time you could
have acquired a single average of a 3D data set with 4 slices. The 2 data
sets would have the same amount of data, however the 3D data set would
have information encoded in the z direction allowing for you to resolve slices.
In this example, Nz was increased by 4. In order to keep the same spatial
resolution in z as the 2D version, the FOVz would also have to be increased
by 4. If the FOVz was not increased then the result would be a higher
resolution in z, but that would come with a penalty in SNR.
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3.2 Method
3.2.1 Data Collection
To collect a spectra in either a phantom or on a human subject, first a
localizer must be run. Then a multi-slice localizer is collected in the axial,
coronal, and transversal directions. Next a 2d/3d CSI sequence is opened and
positioned as shown in figure 3.1. This positioning avoids the air pockets in
the sinus cavities, fluid filled ventricles, and the fat around the skull. The
parameters used were specified TR = 2000 ms, TE = 30 ms, averages = 10,
slices = 4 (3d only), thickness = 20 (per slice) millimeters, and the slices
from the localizer are parsed through in all three directions to ensure that
an optimal view has been selected within the ROI. An auto-shim is run and
then values are adjusted until the FWHM is less than 25 Hz and the T2*
is greater than 20 ms, preventing the disadvantage often observed in CSI of
poor quality shimming. The 2d/3d CSI is then run and finally a sense map
with the same location and time frame is collected for reconstruction of a
field map.
Figure 3.1: Configuration of 3D CSI sequence in human subject
3.2.2 Data Processing
Reconstruction is performed using the sense map. Then the spectra is pro-
cessed with LCModel or jMRUI to identify peaks and peak amplitudes.
LCModel is an automated commercial software for the analysis MR Spec-
troscopy data in the frequency domain [41]. While LCModel operates in a
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UNIX environment, it does utilize a graphical interface, LCMGui, which au-
timatically calculates the metabolite concentrations and Cramer-Rao lower
bounds as a ratio relative to creatine and phosphocreatine [41]. This program
requires little user input due to the utilization of basis spectra sets (which
must closely match the data) to produce a best fit for peaks that overlap.
jMRUI software utilizes a java-based GUI to analyze time-domain FIDs
[30]. Compared to LCModel, jMRUI requires more user information; how-
ever, also allows the user to manipulate spectra through preprocessing and
quantitation steps. There are number of preprocessing steps in the time
domain. HLSVD filter and HLSVDPro-filter [32] are used for the suppres-
sion of water molecules. The time-domain QUALITY deconvolution method
helps to remove magnetic field inhomogeneity, contribution to the line-shape
yielding Lorenzian line shapes [6]. The Cadzow function is used to filter the
signal [1]. The jMRUI program also uses gabor as a tool for peak extraction
and dynamic phase correction. Mathematical operators, like addition, sub-
traction, multiplication of the signal with a scalar quantity, are available for
the normalization of a signal or over a series of signals. It also provides the
preprocessing operator to convert an echo signal into an FID signal.
3.2.3 Phase Encoding
The magnetization phase is the relative angular orientation of the magneti-
zation within the rotating frame’s transverse plane [7]. Phase encoding and
frequency encoding are used sequentially to generate a 2D MR image. The
3rd dimension is obtained by by slice selection.
Phase encoding occurs through a gradient coil. The magnetization pro-
cession frequency becomes dependent on spatial (anatomic) coordinates and
thus acquires a phase that depends on spatial these coordinates.
When a gradient coil turns on, Bo, depends in a linear fashion the spatial
location, y:
Bz(y) = Bo + yGz(y) (3.1)
The precession frequency is also linearly dependent on location:
ω(y) = σ(Bo + σGz(y)) (3.2)
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Also linearly dependent on location is the phase which is acquired during a
gradient pulse of duration t:
p(y, t) = ωt = σ(Bo + σGz(y))t (3.3)
MR signals are collected with a number of unique phase encodes that are
usually a set of steps or increments. The signal phase oscillates in a way that
depends on location along the phase encode gradient direction. The gradient
pulse duration and maximum amplitude are set such that a line of protons
at the edge of the FOV has a phase advance of 180° with each phase encode
step. Typically, the slice is selected with an RF pulse in the presence of a
magnetic field gradient and multiple phase encoded signals are collected in
the presence of a frequency encoding gradient. To reconstruct an image, a
Fourier Transform (FT) of each phase encoded signal is done. The FT is
done at each frequency to get a result and intensity renderings are utilized.
3.2.4 K-space Encode
K-space contains most of the image intensity is in the center of the space and
information about the fine features is found toward the periphery. K-space
and real-space images can be calculated from each other using the FT:
f(x) =
∫ ∞
−∞
F (k)e2piikxdk (3.4)
or the inverse-FT:
F (k) =
∫ ∞
−∞
f(x)e−2piikxdx (3.5)
One approach to MR encoding is k-space line scanning which is a method-
ology that quickly samples one line of k-space along the frequency encode
direction and then advances the phase encode step to sample the next line
of k-space. Frequency encoded signal acquisition is relatively fast depending
on gradient strength, T2, and T2*. Phase encoded signal acquisition is much
slower. This method can only acquire one TR per phase encode step and
the length of the TR depends on the relaxation characteristics and desired
contrast.
The k-space line scanning approach is N-times more efficient than point
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scanning where N is the desired resolution in the frequency direction.
3.2.5 Signal to Noise
Currently, the major challenge in acquiring good data is the low signal to
noise (SNR) of the metabolites. This problem arises from low metabolite
concentrations (1-10mM) with respect to the water signal ( 50M) [7]. In
structural MRI, where water is the primary signal source, the length of the
scan is minutes long with millimeter resolution, however, CSI scan times are
on the order of tens of minutes and the resolution is only on the centimeter
scale. The length of the scan time and low resolution is required to improve
SNR, which is related to the following equation [7].
SNR ∝ (δx)(δy)(δz)
√
totalreadoutinterval (3.6)
3.3 2D CSI versus 3D CSI
Within a set period of time, it is possible to acquire many averages over a
limited spatial region with a 2d sequence. In the same period of time a 3d
sequence may acquire fewer averages over the same sized region or the same
number of averages over a smaller region. Here we consider the relative speed
of a 2D CSI versus a 3D CSI, but it is also important to consider the SNR.
If it is assumed for a 3D CSI that SNR = X, then for the 2D case, the SNR
= X√
#Zslicesacquired
= X√
8
[7]. For a 3D acquisition, data any point in the k-
space is acquired by exciting the entire space; thereby giving it contributions
from the eight slices. Data in 2D, the data for any point in the k-space comes
from only one slice. For any number of slices, the factor between 2D and 3D
SNR is 1√
#ofslices
.
If a 2D scan utilizes the same time as a 3D scan, eight acquisitions of the
2D scan can be collected and averaged. If a 2d scan with eight averages and
a 3d scan with one average with eight slices collected, both will take the same
amount of time and have an SNR increased by
√
8 when compared to one
average of a 2d scan.
This calculation illustrates the speed of 2D acquisitions and the diminished
SNR of a 2D acquisition when compared to a 3D acquisition.
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Figure 3.2: Scan setup for Phantom of Water and Oil
Pictured in figure 3.2 is the isocenter setup for the acquisition of phantom
data, with water suppression, a field of view of 200x200 square millimeters,
a volume of interest of 100x100 square millimeters, slice thickness of 20 mil-
limeters in 2d acquisitions and a third dimension of 80 millimeters in 3d
acquisitions, and TE and TR set to 30 ms and 2000 ms, respectively.
The spectra collected exhibit two distinct peaks, water and oil. By apply-
ing a hamming filter the data the noise and water signals decrease and the
oil peak become more defined (figure 3.3).
The 3d CSI is similarly improved via filtering. Comparison of the 2d and
3d CSI in figure 3.4 reveals the improvement of the spectral quality.
This improvement is consistently observed throughout the acquisitions.
Figure 3.5 compares the mean of the SNR across one column of data or a
line in image space.
The signal to noise ratio is referenced in decibels relative to the carrier or
dBc of the real-valued sinusoid input, using a periodogram of the same length
as the input, and excluding the first six harmonics. The maximum SNR of the
2d CSI is 31.13 dBc, which is similar to the 3d CSI which reached 34.85 dBc.
The average for the 2d CSI at 8.61 dBc was similar to the 3d acquisition at
10.69 dBc. The calculated maximum and average SNR appear approximately
equivalent in 2d and 3d acquisitions, but it is important to consider figure 3.5
which indicates that there is more specified improvement, as much as 5 dBc,
in peripheral spatial locations. This is a finding of particular importance
since it indicates increased SNR according to spatial location. Figure 3.6
shows the phantom corresponds spatially to the increased SNR in figure 3.5.
In more specialized phantoms it can be shown that 3d analysis provides
improved information as well. Utilizing the same collection parameters as
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Figure 3.3: Original and filtered data of 2d CSI. The filtered data has the
downfall of introducing some ringing around large peaks which can be seen
around the water peak. In the original data this peak has a small secondary
peak due to effects from water suppression so this is worsened by the
filtering process, however, the overall SNR is improved since the amplitude
of the peaks water and oil signals are increased.
Figure 3.4: Comparison of spectral quality between a filtered sample 2d and
3d spectra. At room temperature, the water peak occurs at 4.7 ppm. The
oil peak can be observed to the right of the water peak and is the only
other observed peak, as expected. The plot of the 2d and 3d data shows
that the 3d data improves spectral quality.
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Figure 3.5: SNR comparison of 2d and 3d data acquisitions. The SNR
increases between 4 and 8 which is where the cylinder of oil sits in the
phantom.
Figure 3.6: Phantom with oil filled cylinder surrounded by water. SNR
increases specifically around object of interest. The specificity of this SNR
increase occurs more with 3d than 2d.
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Figure 3.7: The spectral image depicts three vials with NAA, creatine,
and/or choline surrounded by red squares and the areas where vials with
water would be surrouded by blue squares. The area in the blue squares
does not vary in contrast, but is known to have these vials since the
phantom is designed as such. The red squares do show altered contrast due
to the metabolite content of the vials.
specified above, data can be obtained and analyzed from a phantom with
five small vials, two containing water and three containing some mixture of
NAA, creatine, and/ or choline is shown in a spectral image in figure 3.7.
Figure 3.8 proves that the metabolites expected are present and also indi-
cates that the 3d spectra in fact shows a higher resolution plot.
Human data is collected using the same parameters as phantom data,
however, it is important to utilize saturation bands when collecting data in
biological samples due to the presence of fat which will result in a large wide
peak. These peaks are set up as shown in figure 3.9.
Samples of both the 2d and 3d spectra can be observed in figure 3.10.
Notably, the 3d spectra has much more definition in the peaks, including the
water peak. The full width half max of the water peak is much narrower in
the 3d spectrum than the 2d spectrum, the metabolites are more visible, and
there is overall much less noise.
Figures 3.12 and 3.13 show the SNR values, respectively, of the original
and filtered data through one column of data. It is important to note that
in a biological sample not all of the metabolite peaks are known so when a
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Figure 3.8: The spectra herein are the 2d and 3d CSIs of a phantom
containing five vials, three of which contain metabolites. The water peak is
at room temperature so it is located at 4.7 ppm. The shift from the water
peak of NAA, creatine, and choline are, respectively, from the water peak,
2.0 ppm, 3.0 ppm, and 3.2 ppm. Thus, the NAA peak is found at 6.7 ppm,
creatine is at 7.7 ppm, and choline is at 7.9 ppm.
Figure 3.9: Example of fat saturation bands utilized to prevent metabolite
peaks in spectrum from being hidden by a large, wide fat peak.
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Figure 3.10: 2d and 3d Spectra for a human subject are depicted. The
water peak is at 4.5 ppm. This is a normal position for body temperature.
Shifted to the right from the water peak NAA, Creatine, and Choline can
be observed. NAA is observed at approximately a 2.0 ppm shift to the right
of water or at 6.5 ppm. Creatine is observed at a 3.0 ppm shift or 7.5 ppm
and Choline is at a 3.2 shift or 7.7 ppm. (For better metabolite peak
visualization, see 3.11)
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Figure 3.11: For better visualization of the metabolite peaks, this figure
contains a smaller viewing window along the spectra containing the
right-most side of the water peaks, NAA, Cr, and Cho. It is important to
note the minimal noise in the 3d (green) spectra and the defined peaks.
Conversely, the 2d (blue) spectra has much more noise and the metabolite
peaks are barely discernible amongst the noise.
filter is applied it can affect the amplitude of the signal as well as the noise,
as observed by the decrease in the 2d and 3d SNR in 3.13.
The average SNR for 2d is 18.7838 dBc and for 3d it is 19.6001 dBc.
There is at approximately equivalent SNR, although it is difficult to asses
due to the lack of homogeneous signal. Similarly, the maximum SNR is about
equivalent, increasing from 34.2233 dBc to 37.7516 dBc between 2d and 3d.
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Figure 3.12: Original 2d and 3d SNR data for human subject averaged
through each column. Illustrates the increased SNR in the 3d data as
compared to the 2d data.
Figure 3.13: Filtered 2d and 3d SNR data for human subject averaged
through each column. The decrease in SNR for both 2d and 3d illustrates
how the filter does not account for unknown metabolite signals that arise in
human data sets.
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CHAPTER 4
SEGMENTATION AND METABOLITE
MAPPING
Proton MRS can be used to detect tissue metabolites that may be markers
of disease or injury. Acquisition and analysis of MRS data is technically
challenging and limited by the spatial resolution and accuracy of metabolite
quantification. Metabolic changes in disease and injury may occur in spatially
specific regions that can not be interpreted from a large single voxel. Thus,
alternative techniques and methods of analysis are beneficial.
Some variation in metabolite concentrations between tissue type, across
brain regions, and age groups is well documented [27, 48, 18]. To account
for variability, results of a particular are commonly compared with a con-
trol group. However, cross-study comparison is difficult due to differences in
brain regions, acquisition parameters, analysis methods, and selection crite-
ria. Additionally, an adequate number of measurements must be acquired to
account for acquisition dependent measurement variability from low signal
to noise (SNR), line shape distortion, spectral contamination from water and
lipids, and variable partial volume contributions.
MRS analysis often utilizes metabolite ratios in order to remove concern
about signal calibration and correction for sensitivity variability detection.
This technique results in information loss. Thus, absolute quantification (and
therefore a calibration procedure) is useful. While absolute quantification
methods for MRSI have been implemented [27, 40] in order to obtain stan-
dardized metabolite concentration units, their requirements for metabolite
and reference relaxation accounting is impractical for clinical studies.
4.1 Motivation
There are considerable clinical diagnostic implications for studies in the brain.
However, the time requirements to resolve metabolite distribution in various
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areas of the brain presents a challenge. Herein, we propose the use of proton
MRS observed metabolite distributions using a chemical shift imaging in or-
der to map a large portion of the brain quickly and with spatial information,
so a normalized metabolite map can be produced with a normalized sig-
nal. Segmentation of tissue types accounts for variable tissue contribution of
metabolites to enable analysis of regional and subject dependent differences
in metabolite distributions.
4.2 Method
A 2d spin echo spectral image with fat saturation bands is acquired of the
region centered on the cortical regions immediately superior to the lateral
ventricles (TR: 2000 ms, TE 30 ms, 16x16 matrix size, thickness: 20 mm)
both with weak water suppression and without water suppression. Following
the scan a T2-weighted sequence with the same center and slice orientation
was acquired in order to register to a high resolution whole-brain MPRAGE
(TR: 2000 msm TE: 2.32 ms, TI: 900 ms, 0.9 x 0.9 x 0.9 mm). Spectral and
metabolite maps were then created using Siemens software embedded in the
MRI scanner computer.
4.3 Spectral Maps and Metabolite Maps
The ROI is covered by a matrix comprised of 16x16 voxels. As seen in figure
4.1, the field of view extends beyond the skull, exposing the voxels within the
ROI to leakage of noise from fat signals; therefore, preventative fat saturation
bands are placed around the skull during the scan.
The MPRAGE (figure 4.1) can be overlain with the spectra for each voxel,
as seen in figure 4.2. This is a valuable tool in identifying problematic areas
that may arise due to anatomy or particular scan settings. Moreover, it pro-
vides a method of viewing reconstructed spectra with respect to the location
from which they were created.
In order to better visualize particular metabolites, a metabolite map can
be created. The map of metabolites seen in figure 4.3 depicts relative con-
centrations of NAA over regions of the brain image.
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Figure 4.1: Initial Brain Image
While NAA is most commonly observed in the brain since it is the most
heavily concentrated metabolite, as observed in 4.3, Creatine and Choline
are also important metabolites due to their relatively high concentrations
and their common use as internal references. Creatine and Choline relative
concentration metabolite maps can be seen, respectively in figures 4.4 and
4.5.
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Figure 4.2: Spectral Map containing localized spectra in each voxel
Figure 4.3: NAA Map with color correlated relative concentrations
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Figure 4.4: Creatine Map with color correlated relative concentrations
Figure 4.5: Choline Map with color correlated relative concentrations
38
CHAPTER 5
CONCLUSION
Herein, the following have been addressed:
1. non-invasive brain temperature measurement via SVS,
2. utilization of 2d and 3d CSI highly specific in vivo and ex vivo mea-
surements, and
3. segmentation, spectral, and metabolite mapping of 2d planes.
In the future, whole brain thermometry and mapping using 3d CSI will
be a possibility. Chapter 3 showed the plausibility of high SNR measure-
ments with 3d CSI. In order to shorten the length of these scans, less mea-
surements will need to be required. Therefore, improved on-line filters and
post-processing filters will be necessary. On-line filtering provides the ad-
vantage of correcting artifact, such as motion, as data is being collected.
Post-processing filters offer the benefit of amplifying signal while reducing
noise. The combination of these techniques will optimize SNR in a short
period of time.
The ability to monitor whole brain temperature and metabolite concen-
tration is important in the identification of dynamic changes and there is a
necessity for speed in a clinical setting. Both in emergency situations and for
the adoption of a new technique, a quick scan with highly indicative findings
is of the utmost value.
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APPENDIX A
DATA COLLECTION
A.1 SVS: Temperature Measurement
1. Localize
2. MPRAGE in axial, transversal, and coronal directions
(a) Open one in each visualization window
3. Open SVS sequence
(a) Sequence >Delta frequency >-2.7 (to account for NAA shift)
(b) System >Save Uncombined (should not be checked)
(c) Contrast >Water suppr. >None or Weak water sup (choice de-
pends on data needs, but stay consistent across sampling and data
sets)
(d) Orientation >adjust for best view
(e) Averages >between 6 and 30 is standard and gives good data
4. Align voxel to area of interest (may need to return to step 2)
(a) Adjust voxel size (Routine) to fit area of interest (standard: 20x20x20,
increasing one or two dimensions to 40 common)
(b) commonly between parietal lobe and sensorimotor area
(c) avoid prefontal lobe as inhomogeneity from sinus cavities is an
issue
5. Move through each MPRAGE to ensure ROIs are good and overlap in
all plains
(a) ***Most difficult step***
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6. Apply fat sat bands
(a) can leave off in some brain scans due to minimal fat around the
skull (ex: babies have no fat around skull)
(b) utilize these in brain scans of heavier patients
(c) necessary for other regions of the body
7. Auto-shim
(a) FWHM >25 Hz
(b) T2* <20 ms
8. Run FIRST SVS without water suppression
9. Readjust water frequency
10. Run next SVS with water suppression or weak water suppression
11. Repeat steps 9 and 10 as desired
12. Save .rda
(a) Open file using patient browser
i. Look for bold file (will vary between runs)
ii. Find subfile where data is automatically stored
(b) To export: Options >Export Raw Data
(c) Put in appropriate drive for export
(d) Must be done for each SVS individually
(e) Save data
13. Save dicom (.ima)
(a) Select all data of interest from patient browser
(b) Export as dicom to appropriate file
(c) Save to external drive
14. Import all SVS files into JMRUI
15. Edit spectra as desired
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16. Save spectra to .txt files
17. Use MATLAB code ”readJMRUImet.m” to extract peak locations
18. Calculate Temperature
(a) Weis et al. Noninvasive monitoring of brain temperature during
mild hypothermia. Mag Res Imag 27(2009). 923-932.
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A.2 CSI: 2d/3d
A.2.1 Common Parameters
• Water Suppression
• No Lipid Suppression
• Saturation Bands in Biological Samples
• TE = 30 - 35 ms
• TR = 2000 ms
• Delta = -2.7 ppm
• 10 measurements
• 1 measurement if Water Suppressed
A.2.2 Steps
1. Run localizer
2. Run localizer with 5+ slices in coronal sagittal, and transversal
3. Open SpiralCSI sequence
4. Set up sat bands (only necessary in biological samples)
5. Shim (FWHM <25 Hz, T2* >20 ms)
6. Run the sequence
7. Open the next sequence
8. Always adjust the frequency between every scan even if not switching
between 2d and 3d
9. Run sensitivity map
10. Copy the center of slice groups & sat regions and Adjust volume to
switch between 2d and 3d scans.
11. To complete adjustment between 2d and 3d scans, the region of interest
and shim must be changed, so open tab on the right of the window to
change the ROI to the appropriate size then check the shim
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12. Continue with next sequence
13. Run a separate sensitivity map for 2d and 3d
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APPENDIX B
RECONSTRUCTION
B.1 SVS
While SVS data can be viewed individually on the Siemens desktop com-
puter, it is valuable to be able to utilize post-processing tools and extrapo-
late information from the spectra. Important tools for such work include the
following.
• jMRUI: a GUI that reads single or multiple data sets with consistency
in either the time or frequency domain and offers the ability to process the
data step by step as desired.
• readJMRUI: this matlab function imports jMRUI edited data to matlab.
• temperature equation: The equation, T = a - [b*(δH2O−ref + c)], can easily
be applied to the matrix imported by readJMRUI.
• dicomreadspectro: is a matlab fuction that reads Siemens DICOM spec-
trum by identifying dicom get tags and dicom read attr functions and allow
visual inspection away from the scanner desktop computer.
• temp svs: is a matlab function that reads in all the data files from a given
folder, determines the spectra for each data file, and provides changes in in
data values spectra
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B.2 CSI: 2d/3d
1. Place data file and sen folder containing sensitivity map into a folder
2. Run the shell script spiralCSI recon to process the data. This will
output images of what the phantom/biological sample looks like and
matrices of spectra.
3. If multiple measurements were taken the averaged result will be con-
tained in ave img.
4. Each of the following will read in the matrix ave img and output results.
• LCModel: the GUI interface identifies spectral peaks and calculates
the metabolite concentrations and Cramer-Rao lower bounds as a ratio
relative to creatine and phosphocreatine for every spectra in a consis-
tent manner. • writeCsi2Lcmodel: Data files that need to be edited
prior to LCModel input or that are in the wrong format for LCModel
can be put into the proper format with this matlab function
• calculateSNR: this matlab function takes input matrix and calculates
SNR for each matrix as well as the average and maximum SNR in the
form of [SNR, aveSNR, maxSNR].
• gausBump: the matlab function applies a Gaussian filter and boosts
the spectral signals.
• hammingFilter: the matlab function applies hamming filter to each
spectra in input matrix.
• peakID: this matlab function identifies spectral peaks for each spec-
tra in input matrix.
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